B
Bradford A. Kay
Researcher at International Centre for Diarrhoeal Disease Research, Bangladesh
Publications - Â 37
Citations - Â 3306
Bradford A. Kay is an academic researcher from International Centre for Diarrhoeal Disease Research, Bangladesh. The author has contributed to research in topics: Cholera vaccine & Cholera. The author has an hindex of 25, co-authored 37 publications receiving 3249 citations. Previous affiliations of Bradford A. Kay include University of Maryland, College Park & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up
John D. Clemens,David A. Sack,Jeffrey R. Harris,F. P. L. Van Loon,Jyotsnamoy Chakraborty,Firoz Ahmed,M. R. Rao,M. R. Khan,Yunus,Nurul Huda,Bonita F. Stanton,Bradford A. Kay,R Eeckels,Stephen D. Walter,Ann-Mari Svennerholm,Jan Holmgren +15 more
TL;DR: Protection was similar against severe and non-severe cholera, but was significantly lower in children who were vaccinated at 2-5 years than in older persons (63% for BS-WC; 68% for WC); and PE was substantially higher against classical cholero than against El Tor cholERA.
Journal ArticleDOI
Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial
John D. Clemens,David A. Sack,Jeffrey R. Harris,Jyotsnamoy Chakraborty,P. K. Neogy,Bonita F. Stanton,Nurul Huda,M. U. Khan,Bradford A. Kay,M. R. Khan,Mohammad Ansaruzzaman,M. Yunus,M. Raghava Rao,Ann-Mari Svennerholm,Jan Holmgren +14 more
TL;DR: Sixty-seven percent fewer episodes of LT-ETEC diarrhea were noted in the BS-WC group than in the WC group during short-term follow-up, but no reduction was evident during the ensuing nine months.
Journal ArticleDOI
Field trial of oral cholera vaccines in Bangladesh
John D. Clemens,Jeffrey R. Harris,Jeffrey R. Harris,M. R. Khan,Bradford A. Kay,Bradford A. Kay,Yunus,Ann-Mari Svennerholm,David A. Sack,David A. Sack,Jyotsnamoy Chakraborty,Bonita F. Stanton,Bonita F. Stanton,M. U. Khan,William L. Atkinson,Jan Holmgren +15 more
TL;DR: For each vaccine protective efficacy was consistent in different age-groups (2-10 years versus greater than 10 years) and for different severities of cholera.
Journal Article
Field trial of oral cholera vaccines in Bangladesh
John D. Clemens,Jeffrey R. Harris,David A. Sack,Jyotsnamoy Chakraborty,Firoz Ahmed,Bonita F. Stanton,M. U. Khan,Bradford A. Kay,Nurul Huda,M. R. Khan,M. Yunus,M. R. Rao,Ann-Mari Svennerholm,Jan Holmgren +13 more
TL;DR: In this paper, the oral B subunit killed whole-cell (BS-WC) and killed wholecell (WC) cholera vaccines was assessed in 63 498 Bangladeshi children aged 2-15 years and women aged over 15 years.
Journal ArticleDOI
Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile.
Myron M. Levine,Catterine Ferreccio,Valeria Prado,Marisol Cayazzo,Paulina Abrego,Juan Martinez,Leonardo Maggi,Mary M. Baldini,Wendy Martin,David R. Maneval,Bradford A. Kay,Linda Guers,Hermy Lior,Steven S. Wasserman,James P. Nataro +14 more
TL;DR: The incidence of diarrhea due to six categories of diarrheogenic Escherichia coli was determined in two pediatric cohorts in a low socioeconomic level community in Santiago, Chile, with access to chlorinated water, finding that Facile transmission of E. coli enteropathogens is occurring in this community despite the availability of potable water.